Conditioned Place Preference Olmstead 1997
Behavioral testing apparatus for assessing drug reward and aversion through conditioned place preference paradigms in laboratory animals.
| Automation Level | semi-automated |
| Species | Mouse, Rat |
The Conditioned Place Preference (CPP) apparatus based on Olmstead 1997 is a behavioral testing system designed to assess drug reward and aversion in laboratory animals. This paradigm measures an animal's preference for an environment previously paired with a pharmacological agent, providing quantitative data on the rewarding or aversive properties of substances. The apparatus enables researchers to evaluate conditioned responses through spatial preference behavior, making it a standard tool for addiction research and drug abuse liability studies.
The system employs a multi-compartment design where animals can freely explore different environments during testing phases. Researchers pair specific compartments with drug administration during conditioning sessions, then measure the animal's spontaneous preference during drug-free test sessions. This methodology provides objective assessment of drug-seeking behavior and conditioned reward responses without requiring operant training or food restriction.
How It Works
The conditioned place preference paradigm operates on principles of classical conditioning and associative learning. During conditioning sessions, animals receive drug injections in one compartment and vehicle injections in another compartment on alternating days. The animal forms an association between the drug's pharmacological effects and the environmental context, creating a conditioned response to spatial cues.
During testing, drug-free animals are allowed to freely explore all compartments while their position and movement are monitored. Increased time spent in the drug-paired compartment indicates conditioned place preference, suggesting rewarding drug effects. Conversely, avoidance of the drug-paired compartment indicates conditioned place aversion, suggesting aversive drug effects. The magnitude of preference or aversion correlates with the strength of the drug's rewarding or aversive properties.
Features & Benefits
Behavioral Construct
- Place preference
- Conditioned reward
- Spatial learning
- Drug seeking behavior
- Associative learning
Automation Level
- semi-automated
Research Domain
- Addiction Research
- Anxiety and Depression
- Behavioral Pharmacology
- Learning and Memory
- Neurodegeneration
- Neuroscience
Species
- Mouse
- Rat
Weight
- 6.06 kg
Dimensions
- L: 65.0 mm
- W: 36.0 mm
- H: 27.0 mm
Comparison Guide
| Feature | This Product | Typical Alternative | Advantage |
|---|---|---|---|
| Protocol Standardization | Based on established Olmstead 1997 methodology | Custom designs may lack validated protocols | Ensures reproducible results consistent with published literature for reliable data comparison. |
| Environmental Control | Configurable multi-modal cue system | Basic systems often provide limited cue options | Enables optimization of conditioning strength while minimizing unconditioned biases. |
| Testing Flexibility | Supports both preference and aversion protocols | Single-purpose designs may limit experimental options | Allows comprehensive assessment of both rewarding and aversive drug properties in one system. |
This system provides validated methodology for place conditioning studies with flexible environmental control and standardized protocols. The design supports comprehensive behavioral assessment for both rewarding and aversive drug effects.
Practical Tips
Conduct all sessions at the same time of day to control for circadian rhythm effects on drug sensitivity and behavior.
Why: Time-of-day variations can significantly impact drug metabolism and behavioral responses.
Test environmental cue effectiveness with naive animals before beginning conditioning to ensure adequate discrimination.
Why: Poor compartment discrimination reduces conditioning strength and data reliability.
Clean apparatus thoroughly between subjects using appropriate disinfectants to eliminate olfactory cues from previous animals.
Why: Residual scents can create unintended conditioning stimuli and confound results.
Monitor animals continuously during sessions rather than relying solely on endpoint measurements for comprehensive behavioral analysis.
Why: Continuous monitoring reveals movement patterns and exploration behaviors that provide additional experimental insights.
If animals show no conditioning response, verify drug dose effectiveness through pilot locomotor activity or other behavioral assays.
Why: Inadequate drug doses may fail to produce detectable conditioned responses despite appropriate methodology.
Ensure proper ventilation when testing volatile compounds or drugs that may affect handler safety through environmental exposure.
Why: Some test compounds can pose health risks through inhalation or dermal contact during handling.
Setup Guide
What’s in the Box
- Main apparatus housing (typical)
- Compartment dividers and environmental cue materials (typical)
- Assembly hardware and mounting components (typical)
- Protocol documentation and setup guide (typical)
- Cleaning and maintenance supplies (typical)
Warranty
ConductScience provides a 1-year manufacturer warranty covering defects in materials and workmanship, along with technical support for setup and protocol optimization.
Compliance
What is the typical duration for conditioning and testing phases in CPP protocols?
Standard protocols involve 4-8 conditioning sessions over 8-16 days, with each session lasting 30-45 minutes. Testing phases typically consist of 15-30 minute sessions conducted 24 hours after the final conditioning session.
How do I control for baseline compartment preferences in experimental design?
Conduct pre-conditioning sessions to identify and exclude animals showing >65% preference for any compartment. Use counterbalanced designs where drug pairing occurs in both initially preferred and non-preferred compartments across subjects.
What environmental cues are most effective for compartment discrimination?
Combine multiple sensory modalities including floor texture differences, visual patterns, and subtle lighting variations. Avoid overly salient cues that could create strong unconditioned preferences independent of drug effects.
How do I distinguish between conditioned place preference and locomotor activation effects?
Monitor total distance traveled and compartment transitions in addition to time spent measurements. Include appropriate control groups receiving vehicle injections to separate conditioning effects from general activity changes.
What constitutes a significant place preference response?
Generally, >60% time spent in drug-paired compartment compared to chance levels (50%) indicates preference. Statistical significance should be determined using appropriate tests comparing pre- and post-conditioning scores or between treatment groups.
How do I optimize the apparatus for different drug classes?
Adjust conditioning session duration and number based on drug pharmacokinetics. Fast-acting drugs may require shorter sessions, while drugs with delayed onset may need extended conditioning periods for optimal association formation.
Have a question about this product?
Accessories
Enhance your setup with compatible accessories
Upgrade Options
